THE TRAVEL TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.
Also called NCT04436653
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 150 participants
- Sponsor
- Beijing Anzhen Hospital
- Changhai Hospital
- Fu Wai Hospital, Beijing, China
- Guangdong Provincial People's Hospital
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- West China Hospital
- Xijing Hospital
- Registry
-
NCT04436653
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04436653. Allocation not applicable; no masking; primary purpose treatment. Start 2020-06-16 (actual); primary completion 2026-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- THE TRAVEL TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve
- Acronym
- TRAVEL
- Condition
- Tricuspid Valve Insufficiency
- Intervention (Device)
- Tricuspid Valve Replacement System
- Lead sponsor
- Changhai Hospital
- Collaborator
- Fu Wai Hospital, Beijing, China
- Collaborator
- Beijing Anzhen Hospital
- Collaborator
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Collaborator
- West China Hospital
- Collaborator
- Xijing Hospital
- Collaborator
- Guangdong Provincial People's Hospital
- Collaborator
- Second Affiliated Hospital, Zhejiang University, School of Medicine
Record details
- Record id
cardio:ct-nct04436653- Content hash
d5c7703403ca369ceec32614d05b7cf63fcbe6dbb41fef43a9a41a4420900905